{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T06:16:00Z","timestamp":1772172960473,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1009380","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000}}],"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T00:00:00Z","timestamp":1630972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM126299"],"award-info":[{"award-number":["R01GM126299"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>The SARS-CoV-2 pandemic highlights the need for a detailed molecular understanding of protective antibody responses. This is underscored by the emergence and spread of SARS-CoV-2 variants, including Alpha (B.1.1.7) and Delta (B.1.617.2), some of which appear to be less effectively targeted by current monoclonal antibodies and vaccines. Here we report a high resolution and comprehensive map of antibody recognition of the SARS-CoV-2 spike receptor binding domain (RBD), which is the target of most neutralizing antibodies, using computational structural analysis. With a dataset of nonredundant experimentally determined antibody-RBD structures, we classified antibodies by RBD residue binding determinants using unsupervised clustering. We also identified the energetic and conservation features of epitope residues and assessed the capacity of viral variant mutations to disrupt antibody recognition, revealing sets of antibodies predicted to effectively target recently described viral variants. This detailed structure-based reference of antibody RBD recognition signatures can inform therapeutic and vaccine design strategies.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1009380","type":"journal-article","created":{"date-parts":[[2021,9,7]],"date-time":"2021-09-07T14:03:14Z","timestamp":1631023394000},"page":"e1009380","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Structural and energetic profiling of SARS-CoV-2 receptor binding domain antibody recognition and the impact of circulating variants"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5330-8306","authenticated-orcid":true,"given":"Rui","family":"Yin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1521-5242","authenticated-orcid":true,"given":"Johnathan D.","family":"Guest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghazaleh","family":"Taherzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ragul","family":"Gowthaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0482-4037","authenticated-orcid":true,"given":"Ipsa","family":"Mittra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Quackenbush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4821-0368","authenticated-orcid":true,"given":"Brian G.","family":"Pierce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,9,7]]},"reference":[{"issue":"7830","key":"pcbi.1009380.ref001","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"F. Krammer","year":"2020","journal-title":"Nature"},{"issue":"12","key":"pcbi.1009380.ref002","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41551-020-00660-2","article-title":"Neutralizing antibodies for the treatment of COVID-19.","volume":"4","author":"S Jiang","year":"2020","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"pcbi.1009380.ref003","doi-asserted-by":"crossref","first-page":"e13105","DOI":"10.15252\/emmm.202013105","article-title":"A comparative analysis of remdesivir and other repurposed antivirals against SARS-CoV-2","volume":"13","author":"A Simonis","year":"2021","journal-title":"EMBO Mol Med"},{"key":"pcbi.1009380.ref004","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","author":"Z Wang","year":"2021","journal-title":"Nature"},{"issue":"6531","key":"pcbi.1009380.ref005","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.abf9302","article-title":"Prospective mapping of viral mutations that escape antibodies used to treat COVID-19","volume":"371","author":"TN Starr","year":"2021","journal-title":"Science"},{"key":"pcbi.1009380.ref006","article-title":"Neutralizing Activity of BNT162b2-Elicited Serum","author":"Y Liu","year":"2021","journal-title":"N Engl J Med"},{"key":"pcbi.1009380.ref007","article-title":"Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine\u2014Preliminary Report","author":"K Wu","year":"2021","journal-title":"N Engl J Med"},{"key":"pcbi.1009380.ref008","article-title":"Antibody Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7","author":"P Wang","year":"2021","journal-title":"Nature"},{"key":"pcbi.1009380.ref009","article-title":"Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant","author":"SA Madhi","year":"2021","journal-title":"N Engl J Med"},{"key":"pcbi.1009380.ref010","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","author":"AJ Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"pcbi.1009380.ref011","article-title":"Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization","author":"Z Liu","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"1","key":"pcbi.1009380.ref012","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.chom.2020.11.007","article-title":"Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition","volume":"29","author":"AJ Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"D1","key":"pcbi.1009380.ref013","doi-asserted-by":"crossref","first-page":"D282","DOI":"10.1093\/nar\/gkaa731","article-title":"CoV3D: a database of high resolution coronavirus protein structures","volume":"49","author":"R Gowthaman","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"pcbi.1009380.ref014","doi-asserted-by":"crossref","first-page":"D392","DOI":"10.1093\/nar\/gkq1021","article-title":"The RCSB Protein Data Bank: redesigned web site and web services","volume":"39","author":"PW Rose","year":"2011","journal-title":"Nucleic acids research"},{"key":"pcbi.1009380.ref015","article-title":"Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein","author":"SJ Zost","year":"2020","journal-title":"Nat Med"},{"issue":"3","key":"pcbi.1009380.ref016","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa2035002","article-title":"REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19","volume":"384","author":"DM Weinreich","year":"2021","journal-title":"N Engl J Med"},{"issue":"3","key":"pcbi.1009380.ref017","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1056\/NEJMoa2029849","article-title":"SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19","volume":"384","author":"P Chen","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"pcbi.1009380.ref018","doi-asserted-by":"crossref","first-page":"1854149","DOI":"10.1080\/19420862.2020.1854149","article-title":"Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline.","volume":"12","author":"M Tuccori","year":"2020","journal-title":"mAbs"},{"key":"pcbi.1009380.ref019","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bbrc.2020.10.012","article-title":"Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies","volume":"538","author":"M Yuan","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"pcbi.1009380.ref020","article-title":"Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies","author":"CO Barnes","year":"2020","journal-title":"Cell"},{"issue":"4","key":"pcbi.1009380.ref021","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology","volume":"183","author":"L Piccoli","year":"2020","journal-title":"Cell"},{"key":"pcbi.1009380.ref022","article-title":"Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient","author":"D Zhou","year":"2020","journal-title":"Nat Struct Mol Biol"},{"issue":"7839","key":"pcbi.1009380.ref023","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"CO Barnes","year":"2020","journal-title":"Nature"},{"issue":"6","key":"pcbi.1009380.ref024","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.immuni.2020.10.023","article-title":"Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity","volume":"53","author":"H Liu","year":"2020","journal-title":"Immunity"},{"issue":"6510","key":"pcbi.1009380.ref025","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.abc5881","article-title":"Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody","volume":"369","author":"Z Lv","year":"2020","journal-title":"Science"},{"issue":"219","key":"pcbi.1009380.ref026","doi-asserted-by":"crossref","first-page":"pl2","DOI":"10.1126\/stke.2192004pl2","article-title":"Computational alanine scanning of protein-protein interfaces","volume":"2004","author":"T Kortemme","year":"2004","journal-title":"Sci STKE"},{"key":"pcbi.1009380.ref027","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","author":"D Pinto","year":"2020","journal-title":"Nature"},{"key":"pcbi.1009380.ref028","article-title":"Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants","author":"M Yuan","year":"2021","journal-title":"Science"},{"issue":"7857","key":"pcbi.1009380.ref029","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"P Wang","year":"2021","journal-title":"Nature"},{"issue":"6534","key":"pcbi.1009380.ref030","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.abg7404","article-title":"Immunity to SARS-CoV-2 variants of concern","volume":"371","author":"DM Altmann","year":"2021","journal-title":"Science"},{"key":"pcbi.1009380.ref031","article-title":"Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization","author":"D Planas","year":"2021","journal-title":"Nature"},{"issue":"10296","key":"pcbi.1009380.ref032","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(21)01462-8","article-title":"AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC","volume":"398","author":"EC Wall","year":"2021","journal-title":"Lancet"},{"key":"pcbi.1009380.ref033","article-title":"Potential Benefits of Expanded COVID-19 Surveillance in the US","author":"DR Holtgrave","year":"2021","journal-title":"JAMA"},{"key":"pcbi.1009380.ref034","article-title":"The antigenic anatomy of SARS-CoV-2 receptor binding domain","author":"W Dejnirattisai","year":"2021","journal-title":"Cell"},{"issue":"4","key":"pcbi.1009380.ref035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/prot.24439","article-title":"Blind prediction of interfacial water positions in CAPRI","volume":"82","author":"MF Lensink","year":"2014","journal-title":"Proteins"},{"key":"pcbi.1009380.ref036","article-title":"An Expanded Benchmark for Antibody-Antigen Docking and Affinity Prediction Reveals Insights into Antibody Recognition Determinants","author":"JD Guest","year":"2021","journal-title":"Structure"},{"key":"pcbi.1009380.ref037","article-title":"CoV-AbDab: the Coronavirus Antibody Database","author":"MIJ Raybould","year":"2020","journal-title":"Bioinformatics"},{"key":"pcbi.1009380.ref038","article-title":"Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite","author":"G Cerutti","year":"2021","journal-title":"Cell Host & Microbe"},{"key":"pcbi.1009380.ref039","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","author":"M McCallum","journal-title":"Cell"},{"issue":"6531","key":"pcbi.1009380.ref040","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.abf4830","article-title":"Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody","volume":"371","author":"CG Rappazzo","year":"2021","journal-title":"Science"},{"key":"pcbi.1009380.ref041","article-title":"Broad sarbecovirus neutralization by a human monoclonal antibody","author":"MA Tortorici","year":"2021","journal-title":"Nature"},{"key":"pcbi.1009380.ref042","article-title":"A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice. bioRxiv","author":"DR Martinez","year":"2021"},{"issue":"5","key":"pcbi.1009380.ref043","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.cell.2020.10.043","article-title":"Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2","volume":"183","author":"AC Walls","year":"2020","journal-title":"Cell"},{"issue":"1","key":"pcbi.1009380.ref044","doi-asserted-by":"crossref","first-page":"18149","DOI":"10.1038\/s41598-020-74949-2","article-title":"A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone","volume":"10","author":"B Zhang","year":"2020","journal-title":"Scientific reports"},{"issue":"6530","key":"pcbi.1009380.ref045","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.abf6840","article-title":"Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice","volume":"371","author":"AA Cohen","year":"2021","journal-title":"Science"},{"issue":"7","key":"pcbi.1009380.ref046","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41592-020-0848-2","article-title":"Macromolecular modeling and design in Rosetta: recent methods and frameworks","volume":"17","author":"JK Leman","year":"2020","journal-title":"Nat Methods"},{"issue":"47","key":"pcbi.1009380.ref047","doi-asserted-by":"crossref","first-page":"18949","DOI":"10.1073\/pnas.1115898108","article-title":"Algorithm discovery by protein folding game players","volume":"108","author":"F Khatib","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pcbi.1009380.ref048","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1006\/jmbi.2001.4662","article-title":"Yet another numbering scheme for immunoglobulin variable domains: an automatic modeling and analysis tool","volume":"309","author":"A Honegger","year":"2001","journal-title":"J Mol Biol"},{"issue":"12","key":"pcbi.1009380.ref049","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/bioinformatics\/btl117","article-title":"Pvclust: an R package for assessing the uncertainty in hierarchical clustering","volume":"22","author":"R Suzuki","year":"2006","journal-title":"Bioinformatics"},{"key":"pcbi.1009380.ref050","volume-title":"NACCESS. 2.1.1 ed: Department of Biochemistry and Molecular Biology","author":"SJ Hubbard","year":"1993"},{"issue":"5","key":"pcbi.1009380.ref051","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1006\/jmbi.1994.1334","article-title":"Satisfying hydrogen bonding potential in proteins","volume":"238","author":"IK McDonald","year":"1994","journal-title":"Journal of molecular biology"},{"issue":"4","key":"pcbi.1009380.ref052","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cell.2020.03.045","article-title":"Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2","volume":"181","author":"Q Wang","year":"2020","journal-title":"Cell"},{"issue":"2","key":"pcbi.1009380.ref053","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.","volume":"181","author":"AC Walls","year":"2020","journal-title":"Cell"},{"issue":"6519","key":"pcbi.1009380.ref054","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.abe3354","article-title":"Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms","volume":"370","author":"MA Tortorici","year":"2020","journal-title":"Science"},{"issue":"6523","key":"pcbi.1009380.ref055","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1126\/science.abe3255","article-title":"An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike","volume":"370","author":"M Schoof","year":"2020","journal-title":"Science"},{"key":"pcbi.1009380.ref056","doi-asserted-by":"crossref","DOI":"10.1101\/2020.09.30.318972","article-title":"LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection. bioRxiv","author":"BE Jones","year":"2020"},{"key":"pcbi.1009380.ref057","doi-asserted-by":"crossref","first-page":"W382","DOI":"10.1093\/nar\/gki387","article-title":"The FoldX web server: an online force field","volume":"33","author":"J Schymkowitz","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"pcbi.1009380.ref058","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pro.2829","article-title":"AB-Bind: Antibody binding mutational database for computational affinity predictions","volume":"25","author":"S Sirin","year":"2016","journal-title":"Protein Sci"},{"issue":"22","key":"pcbi.1009380.ref059","doi-asserted-by":"crossref","first-page":"14116","DOI":"10.1073\/pnas.202485799","article-title":"A simple physical model for binding energy hot spots in protein-protein complexes","volume":"99","author":"T Kortemme","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"pcbi.1009380.ref060","doi-asserted-by":"crossref","first-page":"e0130433","DOI":"10.1371\/journal.pone.0130433","article-title":"A Web Resource for Standardized Benchmark Datasets, Metrics, and Rosetta Protocols for Macromolecular Modeling and Design","volume":"10","author":"OC S","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"pcbi.1009380.ref061","first-page":"2908","volume":"11","author":"D Wu","year":"2020","journal-title":"Structural basis for oligoclonal T cell recognition of a shared p"},{"issue":"21","key":"pcbi.1009380.ref062","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1021\/acs.jpcb.7b11367","article-title":"Flex ddG: Rosetta Ensemble-Based Estimation of Changes in Protein-Protein Binding Affinity upon Mutation","volume":"122","author":"KA Barlow","year":"2018","journal-title":"J Phys Chem B"},{"issue":"4","key":"pcbi.1009380.ref063","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jmb.2008.05.023","article-title":"Backrub-like backbone simulation recapitulates natural protein conformational variability and improves mutant side-chain prediction","volume":"380","author":"CA Smith","year":"2008","journal-title":"J Mol Biol"},{"issue":"3","key":"pcbi.1009380.ref064","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic Local Alignment Search Tool","volume":"215","author":"SF Altschul","year":"1990","journal-title":"J Mol Biol"},{"key":"pcbi.1009380.ref065","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H. Wickham","year":"2016"},{"key":"pcbi.1009380.ref066","article-title":"factoextra: Extract and Visualize the Results of Multivariate Data Analyses","author":"A Kassambara","year":"2020"},{"issue":"18","key":"pcbi.1009380.ref067","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Z Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"6483","key":"pcbi.1009380.ref068","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"D Wrapp","year":"2020","journal-title":"Science"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1009380","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T15:05:02Z","timestamp":1673190302000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1009380"}},"subtitle":[],"editor":[{"given":"Charlotte M.","family":"Deane","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,7]]},"references-count":68,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1009380","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.03.21.436311","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,7]]}}}